Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Fumi Goshima"'
Autor:
Takeshi Suzuki, Yoshitaka Sato, Yusuke Okuno, Fumi Goshima, Tadahisa Mikami, Miki Umeda, Takayuki Murata, Takahiro Watanabe, Koichi Watashi, Takaji Wakita, Hiroshi Kitagawa, Hiroshi Kimura
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-11 (2022)
A genome-wide CRISPR screen for HSV-1 host factors using near-haploid HAP1 cells revealed PAPSS1 as an essential factor for heparan sulfate biosynthesis and HSV-1 infection, and identified several other host factors also involved in both processes.
Externí odkaz:
https://doaj.org/article/05db53bb5f7248fba5b299dbb17d5bd2
Autor:
Gaku Takano, Shinichi Esaki, Fumi Goshima, Atsushi Enomoto, Yoshimi Hatano, Haruka Ozaki, Takahiro Watanabe, Yoshitaka Sato, Daisuke Kawakita, Shingo Murakami, Takayuki Murata, Yukihiro Nishiyama, Shinichi Iwasaki, Hiroshi Kimura
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 220-227 (2021)
Prognosis for advanced oral carcinoma remains poor. Oncolytic virotherapy uses replication-competent viruses to infect and kill only the tumor cells. However, it has been difficult to investigate the oncolytic activity of viruses against oral carcino
Externí odkaz:
https://doaj.org/article/d830ed6dd94a4d71905d92ea90a9657d
Autor:
Masahiro Yoshida, Takahiro Watanabe, Yohei Narita, Yoshitaka Sato, Fumi Goshima, Hiroshi Kimura, Takayuki Murata
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract The Epstein-Barr virus (EBV) is a gamma-herpesvirus associated with several malignancies. It establishes a latent infection in B lymphocytes and is occasionally reactivated to enter the lytic cycle. Here we examined the role of the EBV gene
Externí odkaz:
https://doaj.org/article/3fb426ac40bb420f8702ee17bcf0ea01
Autor:
Takaya Ichikawa, Yusuke Okuno, Yoshitaka Sato, Fumi Goshima, Hironori Yoshiyama, Teru Kanda, Hiroshi Kimura, Takayuki Murata
Publikováno v:
mSphere, Vol 3, Iss 6 (2018)
ABSTRACT Epigenetic modifications play a pivotal role in the expression of the genes of Epstein-Barr virus (EBV). We found that de novo EBV infection of primary B cells caused moderate induction of enhancer of zeste homolog 2 (EZH2), the major histon
Externí odkaz:
https://doaj.org/article/26a55b52c00c490fbc4d329b80d1d6b7
Autor:
Masahiro Yoshida, Takayuki Murata, Keiji Ashio, Yohei Narita, Takahiro Watanabe, H. M. Abdullah Al Masud, Yoshitaka Sato, Fumi Goshima, Hiroshi Kimura
Publikováno v:
Frontiers in Microbiology, Vol 8 (2017)
Latent membrane protein 1 (LMP1) is a major oncogene encoded by Epstein–Barr virus (EBV) and is essential for immortalization of B cells by the virus. Previous studies suggested that several transcription factors, such as PU.1, RBP-Jκ, NFκB, EBF1
Externí odkaz:
https://doaj.org/article/0cc55b77c916449c93fd091a3fb87459
Autor:
Yusuke Yanagi, H. M. Abdullah Al Masud, Takahiro Watanabe, Yoshitaka Sato, Fumi Goshima, Hiroshi Kimura, Takayuki Murata
Publikováno v:
Viruses, Vol 11, Iss 3, p 285 (2019)
Epstein–Barr virus (EBV) is a ubiquitous virus that causes infectious mononucleosis and several types of cancer, such as Burkitt lymphoma, T/NK-cell lymphoma, and nasopharyngeal carcinoma. As a herpesvirus, it encodes more than 80 genes, many of wh
Externí odkaz:
https://doaj.org/article/9d135c7cfc1e43fd98470206c0d18867
Autor:
Takayuki Murata, Seiko Iwata, Mohammed Nure Alam Siddiquey, Tetsuhiro Kanazawa, Fumi Goshima, Daisuke Kawashima, Hiroshi Kimura, Tatsuya Tsurumi
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63566 (2013)
Epstein-Barr virus (EBV) LMP1 is a major oncoprotein expressed in latent infection. It functions as a TNFR family member and constitutively activates cellular signals, such as NFκB, MAPK, JAK/STAT and AKT. We here screened small molecule inhibitors
Externí odkaz:
https://doaj.org/article/f364e4c26225431785d55e124b3597fb
Autor:
Kensei Gotoh, Yoshinori Ito, Seiji Maruo, Kenzo Takada, Terukazu Mizuno, Masaaki Teranishi, Seiichi Nakata, Tsutomu Nakashima, Seiko Iwata, Fumi Goshima, Shigeo Nakamura, Hiroshi Kimura
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25490 (2011)
Epstein-Barr virus (EBV) may cause a variety of virus-associated diseases, but no antiviral agents have yet been developed against this virus. Animal models are thus indispensable for the pathological analysis of EBV-related infections and the elucid
Externí odkaz:
https://doaj.org/article/b28ef16ca411415582114558f920f465
Autor:
Hiroshi Kimura, Takayuki Murata, Fumi Goshima, Yoshinori Ito, Michio Suzuki, Yoshitaka Sato, Mohammed Siddiquey, Seiko Iwata, Yutaka Hiramatsu, Tetsuhiro Kanazawa
Summary of patients with EBV-associated lymphoproliferative diseases and CCR4 expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f485b3c8576353b2cc599bd199d751
https://doi.org/10.1158/1078-0432.22460613.v1
https://doi.org/10.1158/1078-0432.22460613.v1
Autor:
Hiroshi Kimura, Takayuki Murata, Fumi Goshima, Yoshinori Ito, Michio Suzuki, Yoshitaka Sato, Mohammed Siddiquey, Seiko Iwata, Yutaka Hiramatsu, Tetsuhiro Kanazawa
Purpose: Epstein–Barr virus (EBV) infects not only B cells but also T cells and natural killer (NK) cells, and T- and NK-cell lymphoproliferative diseases (T/NK-LPD) that are refractory to conventional chemotherapies may develop. To identify a mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b6466a7355a8ece66129983b9e3325
https://doi.org/10.1158/1078-0432.c.6524547.v1
https://doi.org/10.1158/1078-0432.c.6524547.v1